RecruitingNCT06357130

Gynaecological Care for Transgender People in France in 2024.

Sponsor

University Hospital, Bordeaux

Enrollment

500 participants

Start Date

Jun 3, 2024

Study Type

OBSERVATIONAL

Conditions

Transgender Management Care

Summary

To date, the transgender population, still poorly characterized, tends to increase. The impact of gender-affirming hormone therapy (GAHT) in this population remains poorly understood, and few data are published on the gynecological repercussions of such therapy. A recent literature review by a French team suggests gynecological follow-up procedures for transgender people.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study surveys transgender people in France to understand their experiences accessing gynecological care — including pelvic exams, cervical cancer screenings, contraception, and sexual health services. Researchers want to identify the barriers transgender people face when seeking this type of care, and use the findings to improve healthcare access and quality for this underserved population. The survey is being conducted in 2024 and will help shape better guidelines for clinicians. **You may be eligible if...** - You identify as a transgender person (transgender woman or transgender man) - You speak French - You are 18 years or older and living in France **You may NOT be eligible if...** - You are under 18 years old Talk to your doctor to see if this study is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaire

A flyer with QR code leading to the online questionnaire will be sent to trans associations and healthcare networks for distribution to the target population.

Locations(1)

Hopital Haut-Lévêque

Pessac, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06357130